Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Glycopyrrolate Injection USP,…
Alembic Pharmaceuticals Limited reported its consolidated financial results for the quarter ending 31st March 2022. Financial HighlightsIndia Branded Business up by 25% in Q4 from INR 358 Cr. in FY21…
Alembic Pharmaceuticals Limited (Alembic)Â today announced that its wholly owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food &…
India’s drug regulator has authorized five new companies to manufacture the life-saving injection used to treat Mucormycosis in an attempt to accelerate the production of the antifungal Amphotericin B. According…
Drug firm Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for Lurasidone Hydrochloride tablets, used to treat bipolar depression. The approved product is therapeutically equivalent to the…
Alembic Pharmaceuticals Ltd has announced Financial Aid of  between 15 lakhs to 50 lakhs to their deceased employees, which is over and above all other benefits applicable. When it Comes to…
Jubilant Pharma Limited (“Jubilant”), a subsidiary of Jubilant Pharmova Limited, announced that it has received a favorable and unanimous judgment from the United States Court of Appeals summarily affirming Jubilant’s…
Drug firm Alembic Pharmaceuticals on Wednesday said it has received approval from the US health regulator for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, used to treat certain types of…
Net Profit up 42% to Rs 1178 crores for the yearAlembic Pharmaceuticals Limited reported its consolidated financial results for the period ending 31st March 2021. Financial Highlights for the QuarterNet…